We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| ALK Abello AS | TG:4AJ0 | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|
| 0.059999 | 0.31% | 19.58 | 145 | 11:05:01 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 19.44 | 19.46 | 19.59 | 19.42 | 19.42 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 09:29:31 | 44 | 19.58 | EUR |
| Date | Time | Source | Headline |
|---|---|---|---|
| 13/3/2025 | 17:06 | UKREG | Annual General Meeting in ALK-Abelló A/S held on 13 March 2025 |
| 07/3/2025 | 13:34 | UKREG | ACARIZAX® approved in Canada for treatment of young children |
| 04/3/2025 | 21:20 | UKREG | Report on transactions with ALK-Abelló A/S B shares and associated.. |
| 27/2/2025 | 20:51 | UKREG | FDA approves ODACTRA® for the treatment of house dust mite allergy in young.. |
| 21/2/2025 | 14:59 | UKREG | Report on transactions with ALK-Abelló A/S B shares and associated.. |
| 19/2/2025 | 13:46 | UKREG | Annual General Meeting in ALK-Abelló A/S on 13 March 2025 |
| 19/2/2025 | 06:32 | UKREG | Annual report 2024: ALK delivers 15% sales growth with profits up 65% |
| 12/2/2025 | 16:02 | UKREG | Invitation to the presentation of ALK’s annual report 2024 on Wednesday, 19.. |
| 30/1/2025 | 09:13 | UKREG | ALK’s house dust mite tablet (ACARIZAX®) now recommended by NICE for use in.. |
| 20/12/2024 | 16:08 | UKREG | ALK – Financial calendar for the 2025 financial year |
ALK Abello AS (4AJ0) Share Charts1 Year ALK Abello AS Chart |
|
1 Month ALK Abello AS Chart |
Intraday ALK Abello AS Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
